MAPK3 and depressive symptom measurement: In human postmortem studies, scientists showed a decreased ERK1/2 activity and expression in the prefrontal cortex and hippocampus, two major brain structures affected by depression (Dwivedi et al. 2001; Liu et al. 2017).